Skip to main content
Erschienen in: Pediatric Nephrology 1/2009

01.01.2009 | Original Article

Lactobacillus colonization status in infants with urinary tract infection

verfasst von: Jung Won Lee, Yoon Hee Shim, Seung Joo Lee

Erschienen in: Pediatric Nephrology | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

To explore the potential protective role of urogenital lactobacilli against urinary tract infection (UTI), lactobacillus cultures were performed on stool and urine specimens and periurethral/vaginal swabs of febrile infants who were suspected of having UTI. Those infants diagnosed with UTI based on the results of the suprapubic urine cultures were allocated to the UTI group (n = 60), and those who had a simple viral illness with negative urine cultures were allocated to the control group (n = 31). Lactobacilli were anaerobically cultured in lactobacillus-specific DifcoTM Rogosa SL agar for 48 h at 37°C and then counted. The lactobacillus colony counts for the stool and urine specimens and periurethral swabs from the UTI group were significantly lower than those for the control group (P < 0.05). The geometric means of stool, periurethra, and urine lactobacilli in the UTI group were significantly lower than those in the control group (P < 0.05). The colony count of the vaginal lactobacillus demonstrated an equivocal difference between the UTI and control group. In conclusion, this is the first prospective case–control study to demonstrate reduced lactobacillus urogenital colonization in infants with UTI. Our results support the view that less urogenital lactobacillus colonization may be a risk factor for UTI in infants even though there is an unclear possibility that the UTI itself could be the cause of the lower lactobacillus colonies.
Literatur
1.
Zurück zum Zitat Usein CR, Damian M, Tatu-Chitoiu D, Capusa C, Fagara R, Mircescu G (2003) Comparison of genomic profiles of Escherichia coli isolates from urinary tract infections. Roum Arch Microbiol Immunol 62:137–154PubMed Usein CR, Damian M, Tatu-Chitoiu D, Capusa C, Fagara R, Mircescu G (2003) Comparison of genomic profiles of Escherichia coli isolates from urinary tract infections. Roum Arch Microbiol Immunol 62:137–154PubMed
2.
Zurück zum Zitat Stamey TA, Sexton CC (1975) The role of vaginal colonization with Enterobacteriaceae in recurrent urinary tract infections. J Urol 113:214–217CrossRefPubMed Stamey TA, Sexton CC (1975) The role of vaginal colonization with Enterobacteriaceae in recurrent urinary tract infections. J Urol 113:214–217CrossRefPubMed
3.
Zurück zum Zitat Newman D (1915) The treatment of cystitis by intravesical injection of lactic bacillus cultures. Lancet 14:330–332CrossRef Newman D (1915) The treatment of cystitis by intravesical injection of lactic bacillus cultures. Lancet 14:330–332CrossRef
4.
5.
Zurück zum Zitat Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE (1998) Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in woman with recurrent urinary tract infections. J Infect Dis 178:446–450CrossRefPubMed Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE (1998) Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in woman with recurrent urinary tract infections. J Infect Dis 178:446–450CrossRefPubMed
6.
Zurück zum Zitat Herthelius M, Gorbach SL, Mollby R, Nord CE, Pettersson L, Winberg J (1989) Elimination of vaginal colonization with Escherichia coli by administration of indigenous flora. Infect Immun 57:2447–2251PubMedPubMedCentral Herthelius M, Gorbach SL, Mollby R, Nord CE, Pettersson L, Winberg J (1989) Elimination of vaginal colonization with Escherichia coli by administration of indigenous flora. Infect Immun 57:2447–2251PubMedPubMedCentral
7.
Zurück zum Zitat Marie TJ, Swantee CA, Hartlen M (1980) Aerobic and anaerobic uretheral flora of healthy females in various physiologic age groups and of females with urinary tract infections. J Clin Microbiol 11:654–659 Marie TJ, Swantee CA, Hartlen M (1980) Aerobic and anaerobic uretheral flora of healthy females in various physiologic age groups and of females with urinary tract infections. J Clin Microbiol 11:654–659
8.
Zurück zum Zitat Reid G, Chan RC, Bruce AW, Costerton JW (1985) Prevention of urinary tract infection in rats with indigenous Lactobacillus casei strain. Infect Immun 49:320–324PubMedPubMedCentral Reid G, Chan RC, Bruce AW, Costerton JW (1985) Prevention of urinary tract infection in rats with indigenous Lactobacillus casei strain. Infect Immun 49:320–324PubMedPubMedCentral
9.
Zurück zum Zitat Asahara T, Nomoto K, Watanuki M, Yokokura T (2001) Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother 45:1751–1760CrossRefPubMedPubMedCentral Asahara T, Nomoto K, Watanuki M, Yokokura T (2001) Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother 45:1751–1760CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Fraga M, Scavone P, Zunino P (2005) Preventive and therapeutic administration of an indigenous lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model. Antonie van Leeuwenhoek 88:25–34CrossRefPubMed Fraga M, Scavone P, Zunino P (2005) Preventive and therapeutic administration of an indigenous lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model. Antonie van Leeuwenhoek 88:25–34CrossRefPubMed
11.
Zurück zum Zitat Martin R, Langa S, Reviriego C, Jiminez E, Marin ML, Xaus J, Fernández L, Rodríguez JM (2003) Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 143:754–758CrossRefPubMed Martin R, Langa S, Reviriego C, Jiminez E, Marin ML, Xaus J, Fernández L, Rodríguez JM (2003) Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 143:754–758CrossRefPubMed
12.
Zurück zum Zitat Marild S, Hansson S, Jodal U, Oden A, Svedberg K (2004) Protective effect of breastfeeding against urinary tract infection. Acta Pediatr 93:164–168CrossRef Marild S, Hansson S, Jodal U, Oden A, Svedberg K (2004) Protective effect of breastfeeding against urinary tract infection. Acta Pediatr 93:164–168CrossRef
13.
Zurück zum Zitat Bruce AW, Reid G (1988) Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infection. Can J Microbiol 34:339–343CrossRefPubMed Bruce AW, Reid G (1988) Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infection. Can J Microbiol 34:339–343CrossRefPubMed
14.
Zurück zum Zitat Reid G, Bruce AW, Taylor M (1995) Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infection. Microecol Ther 23:32–45 Reid G, Bruce AW, Taylor M (1995) Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infection. Microecol Ther 23:32–45
15.
Zurück zum Zitat Reid G, Bruce AW, Taylor M (1992) Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infection. Clin Ther 14:11–16PubMed Reid G, Bruce AW, Taylor M (1992) Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infection. Clin Ther 14:11–16PubMed
16.
Zurück zum Zitat Gerasimov SV (2004) Probiotic prophylaxis in pediatric recurrent urinary tract infection. Clin Pediatr 43:95–98CrossRef Gerasimov SV (2004) Probiotic prophylaxis in pediatric recurrent urinary tract infection. Clin Pediatr 43:95–98CrossRef
17.
Zurück zum Zitat Lee SJ, Shim YH, Cho SJ, Lee JW (2007) Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol 22:1315–1320CrossRefPubMed Lee SJ, Shim YH, Cho SJ, Lee JW (2007) Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol 22:1315–1320CrossRefPubMed
18.
Zurück zum Zitat Chan RC, Bruce AW, Reid G (1984) Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherence of gram-negative uropathogens by competitive exclusion. J Urol 131:596–601CrossRefPubMed Chan RC, Bruce AW, Reid G (1984) Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherence of gram-negative uropathogens by competitive exclusion. J Urol 131:596–601CrossRefPubMed
19.
Zurück zum Zitat Velraeds MC, van der Mei HC, Reid G, Busscher HJ (1996) Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactant from lactobacillus isolates. Appl Environ Microbiol 62:1958–1963PubMedPubMedCentral Velraeds MC, van der Mei HC, Reid G, Busscher HJ (1996) Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactant from lactobacillus isolates. Appl Environ Microbiol 62:1958–1963PubMedPubMedCentral
20.
Zurück zum Zitat Osset J, Bartolome RM, Garcia E, Andreu A (2001) Assessment of the capacity of lactobacillus to inhibit the growth of uropathogens and block their adhesion to vagina epithelial cells. J Infect Dis 183:485–491CrossRefPubMed Osset J, Bartolome RM, Garcia E, Andreu A (2001) Assessment of the capacity of lactobacillus to inhibit the growth of uropathogens and block their adhesion to vagina epithelial cells. J Infect Dis 183:485–491CrossRefPubMed
21.
Zurück zum Zitat Gill HS, Rutherfurd KJ, Prasad J, Gopal PK (2000) Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr 83:167–176CrossRefPubMed Gill HS, Rutherfurd KJ, Prasad J, Gopal PK (2000) Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr 83:167–176CrossRefPubMed
22.
Zurück zum Zitat Matsuzaki T, Chin J (2000) Modulating immune responses with probiotic bacteria. Immunol Cell Biol 78:67–73CrossRefPubMed Matsuzaki T, Chin J (2000) Modulating immune responses with probiotic bacteria. Immunol Cell Biol 78:67–73CrossRefPubMed
23.
Zurück zum Zitat Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82:103–108CrossRefPubMed Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82:103–108CrossRefPubMed
24.
Zurück zum Zitat Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B (2001) Oral probiotics can resolve urogenital infection. FEMS Immunol Microbiol 30:49–52CrossRef Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B (2001) Oral probiotics can resolve urogenital infection. FEMS Immunol Microbiol 30:49–52CrossRef
25.
Zurück zum Zitat Reid G, Bruce AW (2006) Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol 24:28–32CrossRefPubMed Reid G, Bruce AW (2006) Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol 24:28–32CrossRefPubMed
26.
27.
Zurück zum Zitat Reid G, Bruce AW (2001) Selection of lactobacillus strains for urogenital probiotic applications. J Infect Dis 183:S77–S80CrossRefPubMed Reid G, Bruce AW (2001) Selection of lactobacillus strains for urogenital probiotic applications. J Infect Dis 183:S77–S80CrossRefPubMed
Metadaten
Titel
Lactobacillus colonization status in infants with urinary tract infection
verfasst von
Jung Won Lee
Yoon Hee Shim
Seung Joo Lee
Publikationsdatum
01.01.2009
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 1/2009
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-008-0974-z

Weitere Artikel der Ausgabe 1/2009

Pediatric Nephrology 1/2009 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.